Agios Pharmaceuticals, Inc. revenue for the last year amounted to 26.82 M USD, the most of which — 26.82 M USD — came from its highest performing source at the moment, Medicines for Cellular Metabolism, the year earlier bringing 14.24 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Agios Pharmaceuticals, Inc. 26.82 M USD, and the year before that — 14.24 M USD.